

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,023.80 | 724.97 | 621.05 | 522.90 | 341.99 |
| Total Expenses | 807.64 | 610.98 | 508.88 | 431.45 | 270.26 |
| Profit Before Tax | 216.16 | 81.90 | 112.17 | 91.45 | 71.73 |
| Profit After Tax | 160.42 | 48.71 | 83.29 | 71.95 | 54 |
| Operating Profit After Depreciation | 222.38 | 119.93 | 114.58 | 97.86 | 77.34 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 570.39 | 427.16 | 263.23 | 205.60 | 186.31 |
| Total Non Current Assets | 757.63 | 602.60 | 309.81 | 229.31 | 197.04 |
| Total Current Assets | 791.64 | 493.30 | 457.13 | 429.57 | 216.23 |
| Total Assets | 1,549.26 | 1,095.90 | 766.94 | 658.88 | 413.27 |
| Total Shareholder's Fund | 1,309.63 | 674 | 593.96 | 522.27 | 166.93 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 118.34 | 125.17 | 65.53 | -11.93 | 27.96 |
| Net Cash Used In Investing Activities | -223.94 | -365.36 | -33.04 | -120.72 | -101.21 |
| Net Cash Used In Financing Activities | 261.12 | 239.36 | -12.25 | 140.26 | 72.11 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,008.17 | 701.37 | 621.05 | 522.90 | 341.94 |
| Total Expenses | 794.59 | 600.51 | 508.83 | 431.45 | 270.21 |
| Profit Before Tax | 213.58 | 69.11 | 112.22 | 91.45 | 71.73 |
| Profit After Tax | 159.55 | 43.68 | 83.34 | 71.95 | 54 |
| Operating Profit After Depreciation | 219.43 | 106.76 | 114.64 | 97.86 | 77.34 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 499.23 | 357.06 | 226.37 | 178.95 | 160.61 |
| Total Non Current Assets | 766.64 | 603.44 | 304.75 | 227.90 | 197.15 |
| Total Current Assets | 771.31 | 467.81 | 454.71 | 426.71 | 213.14 |
| Total Assets | 1,537.95 | 1,071.25 | 759.46 | 654.61 | 410.29 |
| Total Shareholder's Fund | 1,311.60 | 675.12 | 586.79 | 518 | 163.95 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 115.93 | 100.85 | 55.73 | -9.69 | 26.38 |
| Net Cash Used In Investing Activities | -234.37 | -337.32 | -20.47 | -122.47 | -100.20 |
| Net Cash Used In Financing Activities | 273.56 | 235.48 | -14.44 | 140.26 | 72.11 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 432.75 | 393.18 | 306.20 | 207.24 | 308.48 |
| Total Expenses | 249.24 | 242.53 | 210.87 | 156.33 | 223.52 |
| Profit Before Tax | 183.80 | 144.67 | 96.19 | 58.08 | 82.84 |
| Profit After Tax | 134.28 | 106.22 | 71.86 | 44.01 | 62.72 |
| Operating Profit after Depreciation | 194.62 | 155.35 | 105.17 | 66.85 | 90.74 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 421.77 | 390.86 | 305.19 | 205.97 | 304.16 |
| Total Expenses | 240.56 | 236.66 | 208.59 | 154.98 | 220.10 |
| Profit Before Tax | 185.86 | 150.71 | 97.28 | 58.93 | 82.81 |
| Profit After Tax | 137.07 | 111.57 | 72.89 | 44.65 | 62.85 |
| Operating Profit after Depreciation | 195.76 | 160.54 | 105.57 | 67.01 | 89.75 |
₹1.5/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
| Fund Name | AUM |
|---|---|
| SBI Healthcare Opportunities Fund | 6.17% |
| Kotak MNC Fund | 5.56% |
| HDFC Pharma and Healthcare Fund | 4.50% |
| ITI Small Cap Fund | 3.76% |
| UTI-Small Cap Fund | 2.45% |
Of Rs 2.5 per share
30 Apr 2026, 02:19 pm
On 30 April 2026
28 Apr 2026, 11:36 am
Ipca Laboratories Ltd, Blue Star Ltd, Westlife Foodworld Ltd and Hyundai Motor India Ltd are among the other losers in the BSE's 'A' group today, 01 April 2026.
01 Apr 2026, 03:01 pm
On 28 January 2026
22 Jan 2026, 10:33 am
Acutaas Chemicals rallied 4.82% to Rs 1,627 after the company's consolidated net profit surged 93.52% to Rs 72.24 crore on 24.1% jump in revenue from operations to Rs 306.19 crore in Q2 Septemerb 2025 over Q2 September 2024.
17 Oct 2025, 01:59 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.